- Previous Close
1,019.35 - Open
1,025.90 - Bid --
- Ask --
- Day's Range
983.55 - 1,029.90 - 52 Week Range
421.35 - 1,060.00 - Volume
148,221 - Avg. Volume
120,321 - Market Cap (intraday)
57.511B - Beta (5Y Monthly) --
- PE Ratio (TTM)
44.02 - EPS (TTM)
22.83 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1,031.00
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
innovacaptab.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: INNOVACAP.NS
View MorePerformance Overview: INNOVACAP.NS
Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INNOVACAP.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INNOVACAP.NS
View MoreValuation Measures
Market Cap
58.33B
Enterprise Value
60.70B
Trailing P/E
44.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.97
Price/Book (mrq)
6.52
Enterprise Value/Revenue
5.17
Enterprise Value/EBITDA
32.51
Financial Highlights
Profitability and Income Statement
Profit Margin
10.05%
Return on Assets (ttm)
7.59%
Return on Equity (ttm)
18.43%
Revenue (ttm)
11.78B
Net Income Avi to Common (ttm)
1.18B
Diluted EPS (ttm)
22.83
Balance Sheet and Cash Flow
Total Cash (mrq)
181.35M
Total Debt/Equity (mrq)
29.17%
Levered Free Cash Flow (ttm)
-1.84B